4.36 A Randomized, Double-Blind, Placebo-Controlled Study of the D1 Receptor Antagonist Ecopipam for Children and Adolescents With Tourette's Disorder

Authors :: Cathy L. Budman
Keith A. Coffman
Tanya K. Murphy
Jorge L. Juncos
Richard E. Chipkin
Kevin J. Black
James T. McCracken
Roger Kurlan
Joseph Jankovic
Donald L. Gilbert
Jon E. Grant
Source :: Journal of the American Academy of Child & Adolescent Psychiatry. 56:S241
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Double blind
Psychiatry and Mental health
chemistry.chemical_compound
Dopamine receptor D1
chemistry
business.industry
Anesthesia
Developmental and Educational Psychology
Antagonist
Placebo-controlled study
Medicine
business
Ecopipam

Tools